Neon Therapeutics, Inc.
Records under this name other than the patents Neon Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 8 of 8 · Back to Neon Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,650,211 | Hla-Based Methods and Compositions and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 11,162,072 | T cell manufacturing compositions and methods Formerly held In force · USPTO record | In force | USPTO record | |
| US 12,303,561 | Protein antigens and uses thereof Formerly held In force · USPTO record | In force | USPTO record | |
| US 12,246,067 | Neoantigens and uses thereof Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,183,272 | Method and Systems for Prediction of Hla Class II-Specific Epitopes and Characterization of CD4+ T Cells Held by another company In force · Medium confidence | In force | Medium confidence | |
| US 11,793,867 | Neoantigens and uses thereof Formerly held In force · USPTO record | In force | USPTO record | |
| US 12,258,581 | T cell manufacturing compositions and methods Formerly held In force · USPTO record | In force | USPTO record | |
| US 12,331,097 | T cell receptor constructs and uses thereof Formerly held In force · USPTO record | In force | USPTO record |